Latest Strategy Changes News

PTR Minerals has reported significant expansion of its Rosewood Titanium Project, confirming extensive high-grade mineralisation and securing $12 million to accelerate development.

IperionX has completed commissioning of its titanium powder and component manufacturing facilities, setting the stage for a major production scale-up backed by US Department of War funding. The company is progressing commercial contracts and advancing its critical minerals project in Tennessee.

Central Petroleum has secured a letter of intent for a long-term gas supply contract through 2034 and expanded its exploration portfolio into the Otway and Cooper Basins, setting the stage for multiple new wells and production growth.

Latrobe Magnesium has resolved a critical manufacturing defect at its Demonstration Plant, enabling Magnesium Oxide production to resume, while securing key financial support for its commercial expansion plans.

Tolu Minerals Limited reports steady progress at its Tolukuma Gold Mine, advancing a major mine expansion project targeting 500 tonnes per day production by the first quarter of 2027. Key infrastructure developments, drilling expansion, and processing plant refurbishments underpin the company’s growth strategy.

White Energy Company Limited has bolstered its balance sheet with a $3.2 million entitlement offer while progressing multiple Australian mineral exploration projects and expanding commercial trials of its Binderless Coal Briquetting technology in South Africa.

Kingsgate Consolidated has delivered a stellar December quarter, boosting cash reserves by 56% and maintaining robust production guidance for FY26 amid favourable gold and silver prices.

Black Rock Mining has marked a significant milestone at its Mahenge Graphite Project with an official groundbreaking ceremony and robust funding progress, setting the stage for rapid development in Tanzania.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

CONNEQT Health has reported a remarkable surge in Pulse device sales, exceeding 200% growth quarter-on-quarter, while advancing its transition to a recurring revenue model through enterprise contracts and consumer subscriptions.

Infinity Metals Limited reported a steady cash position of A$2.25 million at the end of December 2025, with operational spending continuing but no new financing activities. The company estimates funding for over five quarters based on current expenditure.

CONNEQT Health Limited reported a strong quarter with over 200% sales growth for its CONNEQT Pulse product and completed a $3.1 million institutional placement, while operational cost reductions support a leaner business model.